Evidence map›Paper›PMID 36621819›Full record

ArticleStroke2023

Using Noncontrast Computed Tomography to Improve Prediction of Intracerebral Hemorrhage Expansion.

Andrea Morotti, Gregoire Boulouis, Jawed Nawabi, Qi Li, Andreas Charidimou, Marco Pasi, Frieder Schlunk, Ashkan Shoamanesh, Aristeidis H Katsanos, Federico Mazzacane and 17 more

Abstract read
In one paragraph

Article in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Andrea MorottiNeurology Unit, Department of Neurological Sciences and Vision, ASST-Spedali Civili, Brescia, Italy (A.M.).ORCID 0000-0002-6558-1155
Gregoire BoulouisNeuroradiology Department, University Hospital of Tours, CEDEX 09, Tours, France (G.B.).ORCID 0000-0001-8422-9205
Jawed NawabiDepartment of Radiology (CCM), Charité - Universitätsmedizin Berlin, Campus Mitte, Humboldt-Universität zu Berlin, Freie Universität Berlin, Berlin Institute of Health, Germany (J.N.).ORCID 0000-0002-1137-0643
Qi LiDepartment of Neurology, The Second Affiliated Hospital of Anhui Medical University, China (Q.L.).ORCID 0000-0002-9144-148X
Andreas CharidimouDepartment of Neurology, Boston University School of Medicine, MA (A.C.).ORCID 0000-0001-5891-337X
Marco PasiNeurology Department, University Hospital of Tours, CEDEX 09, France (M.P.).ORCID 0000-0001-9976-2459
Frieder SchlunkBerlin Institute of Health (BIH), BIH Biomedical Innovation Academy, Germany (J.N., F.S.).
Ashkan ShoamaneshDivision of Neurology, McMaster University and Population Health Research Institute, Hamilton, ON, Canada (A.S., A.H.K.).ORCID 0000-0002-2802-1626
Aristeidis H KatsanosDivision of Neurology, McMaster University and Population Health Research Institute, Hamilton, ON, Canada (A.S., A.H.K.).ORCID 0000-0002-6359-0023
Federico MazzacaneU.C. Malattie Cerebrovascolari e Stroke Unit, IRCCS Fondazione Mondino, Pavia, Italia (F.M., A.C.).ORCID 0000-0002-2224-8002
Giorgio BustoDepartment of Biomedical Experimental and Clinical, Neuroradiology, University of Firenze, AOU Careggi, Firenze, Italy (G.B., E.F.).
Francesco ArbaStroke Unit, AOU Careggi, Firenze, Italia (F.A.).ORCID 0000-0003-3941-7383
Laura BrancaleoniIRCCS Istituto delle Scienze Neurologiche di Bologna,UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italia (L.B., S.G., A.Z.).ORCID 0000-0002-9891-9183
Sebastiano GiacomozziIRCCS Istituto delle Scienze Neurologiche di Bologna,UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italia (L.B., S.G., A.Z.).ORCID 0000-0003-2859-670X
Luigi SimonettiIRCCS Istituto delle Scienze Neurologiche di Bologna, Unità di Neuroradiologia, Ospedale Maggiore, Bologna, Italia (L.S.).ORCID 0000-0002-5238-4865
Andrew D WarrenJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0002-5832-8178
Michele LaudisiClinica Neurologica, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Università degli studi di Ferrara, Ospedale Universitario S. Anna, Ferrara, Italia (M.L., I.C.).ORCID 0000-0001-6192-9137
Anna CavalliniU.C. Malattie Cerebrovascolari e Stroke Unit, IRCCS Fondazione Mondino, Pavia, Italia (F.M., A.C.).ORCID 0000-0002-5227-1502
Edip M GurolJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0002-2169-4457
Anand ViswanathanJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0001-5398-1816
Andrea ZiniIRCCS Istituto delle Scienze Neurologiche di Bologna,UOC Neurologia e Rete Stroke Metropolitana, Ospedale Maggiore, Bologna, Italia (L.B., S.G., A.Z.).ORCID 0000-0003-1486-4507
Ilaria CasettaClinica Neurologica, Dipartimento di Scienze Biomediche e Chirurgico Specialistiche, Università degli studi di Ferrara, Ospedale Universitario S. Anna, Ferrara, Italia (M.L., I.C.).ORCID 0000-0003-4099-8875
Enrico FainardiDepartment of Biomedical Experimental and Clinical, Neuroradiology, University of Firenze, AOU Careggi, Firenze, Italy (G.B., E.F.).ORCID 0000-0003-0477-724X
Steven M GreenbergJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0003-1792-8887
Alessandro PadovaniDepartment of Clinical and Experimental Sciences, Neurology Unit, University of Brescia, Italy (A.P.).
Jonathan RosandJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0002-1014-9138
Joshua N GoldsteinJ.P. Kistler Stroke Research Center, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (A.C., A.D.W., E.M.G., A.V., S.M.G., J.R., J.N.G.).ORCID 0000-0002-6406-1828

Funding

Predictors of hematoma expansion in acute intracerebral hemorrhageK23NS059774 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GOLDSTEIN, JOSHUA N · 2009 to 2013
$865k
NINDS NIH HHS K23 NS059774
6 · The paper itself

Abstract

backgroundNoncontrast computed tomography hypodensities are a validated predictor of hematoma expansion (HE) in intracerebral hemorrhage and a possible alternative to the computed tomography angiography (CTA) spot sign but their added value to available prediction models remains unclear. We investigated whether the inclusion of hypodensities improves prediction of HE and compared their added value over the spot sign.

methodsRetrospective analysis of patients admitted for primary spontaneous intracerebral hemorrhage at the following 8 university hospitals in Boston, US (1994-2015, prospective), Hamilton, Canada (2010-2016, retrospective), Berlin, Germany (2014-2019, retrospective), Chongqing, China (2011-2015, retrospective), Pavia, Italy (2017-2019, prospective), Ferrara, Italy (2010-2019, retrospective), Brescia, Italy (2020-2021, retrospective), and Bologna, Italy (2015-2019, retrospective). Predictors of HE (hematoma growth >6 mL and/or >33% from baseline to follow-up imaging) were explored with logistic regression. We compared the discrimination of a simple prediction model for HE based on 4 predictors (antitplatelet and anticoagulant treatment, baseline intracerebral hemorrhage volume, and onset-to-imaging time) before and after the inclusion of noncontrast computed tomography hypodensities, using receiver operating characteristic curve and De Long test for area under the curve comparison.

resultsA total of 2465 subjects were included, of whom 664 (26.9%) had HE and 1085 (44.0%) had hypodensities. Hypodensities were independently associated with HE after adjustment for confounders in logistic regression (odds ratio, 3.11 [95% CI, 2.55-3.80];

conclusionsNoncontrast computed tomography hypodensities provided a significant added value in the prediction of HE and appear a valuable alternative to the CTA spot sign. Our findings might inform future studies and suggest the possibility to stratify the risk of HE with good discrimination without CTA.

Indexed as

Cerebral HemorrhageTomography, X-Ray ComputedComputed Tomography AngiographyHematomaHumansProspective StudiesRetrospective Studiescomputed tomographyhematoma expansionintracerebral hemorrhageROC curvestroke

Identifiers

PMID36621819
PMCPMC10037534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.